Predictive markers for neoadjuvant chemotherapy in advanced squamous cell carcinoma of maxillary sinus: Preliminary report

References

• Stern SJ, Goepfert H, Clayman G, Byers R, Ang KK, el-Naggar AK, Squamous cell carcinoma of the maxillary sinus. Arch Otolaryngol Head Neck Surg 1993;119:964–9.
   PubMedGoogle Scholar
• Rosenthal DI, Barker JL Jr, El-Naggar AK, Glisson BS, Kies MS, Diaz EM Jr, Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 2004;101:2567–73.
   PubMed Web of Science ®Google Scholar
• Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184–94.
   PubMed Web of Science ®Google Scholar
• Seiwert TY, Cohen EE. State-of-the-art management of locally advanced head and neck cancer. Br J Cancer 2005;92:1341–8.
   PubMed Web of Science ®Google Scholar
• Katori H, Tsukuda M, Mochimatu I, Mochimatu I, Ishitoya J, Kawai S, Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Br J Cancer 2004;90:348–52.
   PubMed Web of Science ®Google Scholar
• Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83–91.
   PubMed Web of Science ®Google Scholar
• Boscolo-Rizzo P, Stellin M, Fuson R, Marchiori C, Gava A, Da Mosto MC. Long-term quality of life after treatment for locally advanced oropharyngeal carcinoma: surgery and postoperative radiotherapy versus concurrent chemoradiation. Oral Oncol 2009;45:953–7.
   PubMedGoogle Scholar
• American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edition. New York, NY: Springer-Verlag; 2003.
   Google Scholar
• Bewick MA, Conlon MS, Lafrenie RM. Polymorphism in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer. J Clin Oncol 2006;24:5645–51.
   PubMed Web of Science ®Google Scholar
• Britten RA, Liu D, Tessier A, Hutchison MJ, Murray D. ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells. Int J Cancer 2000;89:453–7.
   PubMed Web of Science ®Google Scholar
• Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, Park D, A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 2001;21:3075–9.
   PubMed Web of Science ®Google Scholar
• De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol 2000;20:7980–90.
   PubMed Web of Science ®Google Scholar
• Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355:983–91.
   PubMed Web of Science ®Google Scholar
• Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705–15.
   PubMed Web of Science ®Google Scholar
• Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. Clin Cancer Res 2007;13:3855–9.
   PubMedGoogle Scholar
• Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 2008;99:167–72.
   PubMed Web of Science ®Google Scholar
• Koh Y, Kim TM, Jeon YK, Kwon TK, Hah JH, Lee SH, Class III b-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Ann Oncol 2008;20:1414–19.
   Google Scholar
• Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, Lindahl T. Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 1996;15:6662–70.
   PubMed Web of Science ®Google Scholar
• Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125–9.
   PubMed Web of Science ®Google Scholar
• Nix PA, Greenman J, Cawkwell L, Stafford ND. Expression of XRCC 1 and ERCC 1 proteins in radioresistant and radiosensitive laryngeal cancer. Cancer Ther 2004;2:47–53.
   Google Scholar